期刊文献+

强心剂及利尿剂治疗心源性肝淤血121例对照研究 被引量:2

Observe and Compare the Therapeutic Effects of Using Cardiac and Diuretic in 121 Patients with Liver Congestion of Congestion Heart Failure
下载PDF
导出
摘要 目的观察强心剂及利尿剂对121例心源性肝淤血患者治疗疗效并进行对比性研究。方法自1994年8月~2002年6月,我科收治的121例以心脏收缩功能障碍为主的心源性肝淤血患者随机分为两组:强心剂组(60例)使用以强心剂洋地黄、磷酸二酯酶抑制剂、拟多巴胺类为主的治疗方案,利尿剂组(61例)使用以利尿剂呋塞米、双氢克脲塞、安体舒通为主的治疗方案,观察肝脏大小、边缘、质地及肝功能恢复情况,并对疗效进行对比性研究。结果121例患者中,利尿剂组中56例有效,4例无效,1例死亡。强心剂组中46例有效,12例无效,2例死亡。利尿剂治疗心源性肝淤血明显优于强心剂,二者对比差异有显著性意义(P<0.05)。结论利尿剂治疗心源性肝淤血优于强心剂,可能是与右心衰时以容量负荷加重、右心室心肌较左心室少有关。其机制有待于进一步探讨。 Objective To observe and compare the therapeutic effects of using cardiac and diuretic in 121 patients with liver congestion of congestive heart failure. Methods 121 patients with liver congestion of congestive heart failure were selected from outpatients of our hospital between August 1994 and June 2002. The patients mainly occurred heart systolic dysfunction. According to random principle, patients were divided into two groups: one group using cardiac digitalis, PDEI, dopamine analogues and the other using diuretic furosemide hydrochloro chiazide, spironolactone. Then we observed liver size, edge, quality and liver function and compare the therapeutic effects. Results Among 61 patients using diuretic, 56 valid, 4 invalid, 1 dead. Among 60 patients using cardiac, 46 validl2 invalid, 2 dead. There was obviously significance in two groups ( P 〈 0. 05). Conclusion This study showed diuretic was more effective than cardiac in treatment patients with live congestion of congestive heart failure.
出处 《实用心脑肺血管病杂志》 2006年第3期229-230,共2页 Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
关键词 心源性肝淤血 强心剂 利尿剂 Liver congestion Congestive heart failure Cardiac
  • 相关文献

参考文献3

共引文献325

同被引文献22

  • 1朱蔚琳,张学刚,黄爱兰,叶凤青,胡彦艳.体外循环后鱼精蛋白拮抗肝素两种方法的临床比较[J].中华临床医师杂志(电子版),2012,6(20):173-174. 被引量:6
  • 2付燕,纪世博,邢卉春.2012年美国肝病研究学会成人肝硬化腹水处理指南解读[J].中国医学前沿杂志(电子版),2013,5(7):71-77. 被引量:16
  • 3那开宪,余平.醛固酮受体拮抗剂在心血管疾病中的应用进展[J].世界急危重病医学杂志,2006,3(1):1100-1103. 被引量:3
  • 4王兽炜,刘维永,张宝仁,等.心脏外科学[M].北京:人民军医出版社,2003:395.
  • 5Dacey LJ, Munoz JJ, Baribeau YR, et al. Reexplorationfor hemorrhage following coronary bypass grafting: incidenceand risk factors [J]. Arch Surg, 1998, 133(4):442-7.
  • 6Moulton MJ, Creswell LL, Mackey ME, et al. Reexplorationfor bleeding is a risk factor for adverse outcomesafter cardiac operations [J]. J Thorac Cardiovasc Surg91996, 111(5): 1037^6.
  • 7贾卓.心功能不全继发肝功能异常的相关研究[D].中国优秀硕士学位论文全文数据库,2012年5 月.
  • 8Teoh KH, Young E, Blackall MH, et al. Gan extraprotamine eliminate heparin rebound following cardiopulmonarybypass surgery [J]. J Thorac Cardiovasc Surg, 2004, 128(2): 211-9.
  • 9Hirsh J, Warkentin ET, Raschke R, et al. Heparin andlow molecular weight heparin: mechanims of action,pharmcokinetics, dosing considerations, monitoring, efficacy,and safety[J]. Chest, 1998, 114(5): 489s-510s.
  • 10Hayashida N, Shoujima T, Teshima H, et al. Clinicaloutcome after cardiac operations in patients with cirrhosisfj].Ann Thorac Surg, 2004, 77(2): 500-5.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部